Eubiologics seeks to hold local phase three clinical trials of its shot called Eucorvac-19. <br /><br />Let's find out more from Seok Kyu Kim, the General Manager of Eubiologics and Giovanni Alingong, the CEO of its Philippine partner, Glovax Biotech Corporation. <br /><br />Visit our website for more #NewsYouCanTrust: https://www.cnnphilippines.com/<br /><br />Follow our social media pages:<br /><br />• Facebook: https://www.facebook.com/CNNPhilippines<br />• Instagram: https://www.instagram.com/cnnphilippines/<br />• Twitter: https://twitter.com/cnnphilippines<br />
